Imu Immunization Foundation Houston, TX - 77060

Imu Immunization Foundation is categorized under Clinics in Houston, TX and active since 2002.

Imu Immunization Foundation was established in 2002, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6214930 by the NAICS.

If you are seeking more information, feel free to contact Eric Smiley, Chief Executive Officer at the company’s single location by writing to 440 Benmar Drive, Houston, Texas TX 77060 or by phoning (281) 260-6600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Imu Immunization Foundation
Contact Person: Eric Smiley, Chief Executive Officer
Address: 440 Benmar Drive, Houston, Texas 77060
Phone Number: (281) 260-6600
Website Address: imunizationclinic.org
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Clinics
SIC Code: 8011
NAICS Code: 6214930
Share This Business:

Imu Immunization Foundation was started in 2002 to provide professional Clinics under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Eric Smiley, Chief Executive Officer for inquiries that concern Imu Immunization Foundation by calling the company number (281) 260-6600, as your correspondence is most welcome. Additionally, the physical location of the single location of Imu Immunization Foundation can be found at the coordinates 29.944036,-95.39926 as well as the street address 440 Benmar Drive in Houston, Texas 77060.

For its online presence, you may visit Imu Immunization Foundation’s website at imunizationclinic.org and engage with its social media outlets through on Twitter and on Facebook.